YM 12617

RN given refers to HCl salt; RN from Toxline; RN not in Chemline 5/85; structure given in first source

Also Known As:

5-(2-((2-ethoxyphenoxy)ethyl)amino)propyl-2-methoxybenzenesulfonamide; YM-12617; amsulosin

Networked: 2 relevant articles (0 outcomes, 2 trials/studies)

1.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/01/1987 - "In the present study a newly synthesized alpha 1-blocker, YM-12617, was tried and evaluated in 77 male patients with mild benign prostatic hyperplasia and in 5 women with micturition difficulties of unknown origin. "
2.	Hypoxia (Hypoxemia) 06/08/1989 - "The present study was designed to determine whether the 1-form of YM-12617, which was developed recently as an alpha 1-adrenoceptor blocker, is capable of protecting the myocardium from hypoxia-induced disturbances of cardiac function and metabolism. " 06/08/1989 - "These results suggest that YM-12617 is capable of protecting the myocardium from hypoxia-induced disturbances of cardiac function and metabolism."